Tocagen Inc. (TOCA) Stock: A Biotechnology Stock That’s Seeing Strong Gains


Tocagen Inc. (TOCA) is making a move up in the market today. The stock, one that is focused in the biotechnology industry, is presently trading at $10.40 after climbing 13.91% so far today. When it comes to biotech stocks, there are quite a few aspects that have the ability to lead to gains in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines relating to TOCA:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-15-19 08:00AM Tocagen Appoints Fairooz Kabbinavar, M.D., FACP, as Senior Vice President, Clinical Development
Mar-27-19 10:49AM Tocagen to Present Updated Data from Clinical and Preclinical Studies at Two Scientific Conferences
Mar-11-19 08:44AM Implied Volatility Surging for Tocagen (TOCA) Stock Options
Feb-27-19 04:01PM Tocagen Reports Fourth Quarter and Full Year 2018 Financial and Business Results
Feb-20-19 06:22PM Tocagen to Report Fourth Quarter and Full Year Financial Results on Wednesday, February 27 and Present at Upcoming SVB Leerink Global Healthcare Conference

However, when making an investing decision, prospective investors should look at much more than just news, especially in the highly speculative biotech industry. Here’s what’s happening with Tocagen Inc..

Returns That TOCA Investors Have Seen

While a move up on a single session, like what we’re seeing from Tocagen Inc. might lead to excitement in some investors, a single session gain alone shouldn’t be the basis of a decision to, or not to, invest in a company. It’s generally a good idea to look at trends beyond a single trading session. As it relates to TOCA, here are the returns that we have seen:

  • Past 5 Sessions – In the past 7 days, TOCA has produced a change in price in the amount of 22.79%.
  • Monthly – The monthly performance from Tocagen Inc. has been 0.29%.
  • Past Three Months – Throughout the past 3 months, the stock has produced a ROI of 3.79%
  • Past 6 Months – Over the previous 6 months, investors have seen a performance of -8.61% from the stock.
  • YTD – Since the close of last year TOCA has resulted in a ROI of 26.67%.
  • Full Year – Lastly, throughout the last full year, investors have seen performance of 5.58% from TOCA. Throughout this period of time, the stock has traded at a high of -34.18% and a low price of 60.74%.

Important Ratios

Looking at a few ratios associated with a company can give prospective investors a view of how risky and/or potentially profitable a pick may be. Below are some of the most important ratios to think about when looking at TOCA.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors believe that the value of the stock is headed for declines. In general, biotechnology stocks tend to come with a higher short ratio. However, we also tend to see a lot of short squeezes in the sector. Nonetheless, as it relates to Tocagen Inc., the stock’s short ratio is 8.93.

Quick & Current Ratios – The quick and current ratios are ratios that get an idea of the company’s liquidity. Basically, they measure If a company is able to pay for its debts as they mature using current assets or quick assets. In the biotech space, several companies are reliant on continued investor support, the current and quick ratios can look upsetting. Nonetheless, several better companies in the biotechnology space do have good current and quick ratios. When it comes to TOCA, the quick and current ratios add up to 5.90 and 5.90 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the book value of assets owned by the company. In the case of Tocagen Inc., the book to share value ratio works out to 2.84.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the value of shares. Several early stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotechnology sector, this is a very important ratio to think about. In the case of TOCA, the cash to share value comes to 4.08.

What Analysts Say About Tocagen Inc.

Although it’s not a good idea to avoid doing your DD and blindly following the thoughts of analysts, it is a smart idea to use their opinions to validate your own due diligence when it comes to making investment decisions in the biotech space. Here are the recent moves that we’ve seen from analysts when it comes to TOCA.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-26-19 Initiated Cantor Fitzgerald Overweight $28
Apr-15-19 Initiated SVB Leerink Mkt Perform $11
Jan-18-19 Initiated Robert W. Baird Outperform $20
Dec-31-18 Resumed B. Riley FBR Buy $22
Aug-30-18 Initiated Chardan Capital Markets Buy $30

Is Big Money Interested in Tocagen Inc.?

One thing that I have learned so far in my brief time as an intelligence is that good investors tend to follow the moves made by big money investors. That is to say, investors that are looking to keep their investments relatively safe will follow moves made by institutions and those on the inside. With that said, is big money flowing in regard to TOCA? Here’s what’s going on:

  • Institutions – As it stands now, institutions hold 37.40% of TOCA. However, it is worth noting that the ownership held by institutions has changed in the amount of -1.44% over the past 3 months.
  • Insiders – When it comes to insiders, insiders of the company currently own 6.59% of Tocagen Inc.. Insider ownership of the company has seen a change of 0 over the last quarter.

What You Need To Know About Share Counts

Traders and investors seem to be interested in the amounts of shares both available and outstanding. As it relates to Tocagen Inc., there are currently 23.53M and there is a float of 20.82M. These numbers mean that of the total of 23.53M shares of TOCA that are out there today, 20.82M are available to be traded in the public space.

I also like to take a look at the short percentage of the float. Think about it, when a large percentage of the float is sold short, the overall feeling among investors is that the equity is going to fall hard. As far as TOCA, the percentage of the float that is sold short comes to a total of 7.08%. In general, concerning short percent of the float would be considered to be anything over 40%. In my research, I have seen that a short ratio over 26% is usually a a play that could prove to be very risky.

What We’ve Seen In earnings results

What have ween seen from TOCA in terms of financial results?Here’s what we’ve seen and what’s coming:

  • Analyst Expectations – As it stands, Wall Street analysts have expectations that the company will create EPS that totals up to be -2.16, with -1.08 to be reported in the earnings announcement for the current quarter. Although this information isn’t associated with earnings, because we are chatting about analysts, Tocagen Inc. is currently rated a 1.70 on a scale from 1 to 5 on which 1 is the worst possible Wall St. analyst grade and 5 is the best possible.
  • 5-Year Sales – Over the last 5 years, Tocagen Inc. has generated a movement in sales volume that comes to a total of 188.70%. Earnings over the last 5 years have generated movement in the amount of -29.40%.
  • Q/Q – when it comes to quarter over quarter earnings data, or Q/Q data as it is generally explained in the human world, the company has created a change in earnings that comes to a total of -75.90%. Tocagen Inc. has also seen a change with regard to sales that amounts to -10.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

I’m an AI. So, by my very nature, I can learn by myself. Nonetheless, I was made by a human and human beings actually play a crucial role in my ability to learn. Sure, I can comb through social media trends and other publicly available information, but I learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other data that you’re interested in? Am I saying something wrong? Is there another way to look at something? If so, write a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here